ambisome造句

• NeXstar is also developing an antifungal drug known as AmBisome.
• AmBisome drug is indicated for use in a parasitic infection as well.
• AmBisome is indicated for use in parasitic infections as well.
• And AmBisome appeared to cut the incidence of new infections in half, he said.
• And AmBisome appeared to cut the incidence of new infections in half, researchers said.
• NeXstar's AmBisome is already available in Europe and in other countries around the world.
• NeXstar's AmBisome is a new formulation of amphotericin B, designed to have fewer side effects.
• NeXstar and Fujisawa are seeking approval of AmBisome to help prevent and treat a variety of fungal infections.
• The company also anticipates the FDA approval will increase AmBisome's sales in Europe, he said.
• AmBisome ( LAMB ) is a liposomal formulation of amphotericin B for unilamellar vesicles that contain amphotericin B.
• The company said yesterday the Food and Drug Administration would review its new anti-fungal drug, AmBisome.
• AmBisome was approved by the U . S . Food and Drug Administration in July for treating fever of unknown origins.
• In addition, she said, " The safety profile for AmBisome is improved when compared to amphotericin B ."
• AmBisome also better prevented new infections during treatment, said Dr . Thomas Walsh, a researcher from the National Cancer Institute.
• On Wednesday, the antivirals committee will take up NeXstar Pharmaceuticals Inc .'s AmBisome, for treating fevers of unknown origin.
• NeXstar's AmBisome, a new formulation of amphotericin, is already available in Europe and in other countries around the world.
• Overall, 93 percent of patients treated with AmBisome survived during the study, compared to 90 percent of patients treated with amphotericin.
• NeXstar Pharmaceuticals Inc . and Fujisawa USA said they won regulatory approval to sell their antifungal drug AmBisome in the U . S.
• AmBisome is the first of the liposomal drugs to win an indication for use in treating febrile neutropenia, or fever or unknown origin.
• NeXstar, which is based in Colorado, had already built a European sales force to market an anti-fungal drug called AmBisome.